Citigroup Reinstates Buy on Bristol-Myers Squibb, Announces $73 Price Target

Citigroup analyst Andrew Baum reinstates Bristol-Myers Squibb (NYSE:BMY) with a Buy and announces $73 price target.

Benzinga · 01/06/2020 14:13

Citigroup analyst Andrew Baum reinstates Bristol-Myers Squibb (NYSE:BMY) with a Buy and announces $73 price target.